IBEX is demonstrating robust revenue growth acceleration, with year-over-year gains exceeding 16% in recent quarters, yet this expansion appears to be fundamentally undermining profitability, as evidenced by gross margin compression of approximately 750 basis ...
Price trend, volume and key moving averages
Trailing total returns as of 9/23/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Sep 10, 2026 | $0.85+0.6% vs $0.84 | $164M+2.7% vs $160M |
Q2 2026 May 6, 2026 | $0.91+6.4% vs $0.85 | $164M+4.7% vs $157M |
Q1 2026 Feb 5, 2026 | $0.87+10.8% vs $0.79 | $164M+4.6% vs $157M |
Q4 2025 Nov 6, 2025 | $0.90+11.1% vs $0.81 | $151M-2.8% vs $156M |
WASHINGTON, Sept. 16, 2026 (GLOBE NEWSWIRE) -- ibex (NASDAQ: IBEX), a global leader in outsourced business services and AI-powered customer experience solutions, today announced it was named a winner in the 13th Annual 2026 Globee® Awards for Excellence.
The specialized tech company published its latest quarterly and annual results.
IBEX Limited (IBEX) Q4 2026 Earnings Call Transcript
IBEX NASDAQ: IBEX reported record fourth-quarter and fiscal 2026 results, supported by double-digit revenue growth, expansion in health tech and other verticals, and increasing traction for its AI agent offerings.
Benchmark IBEX against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for IBEX Limited (IBEX)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $41.58 | $559.97M | 17.62 | 9.77% | 6.6% | 24.57% | — | |
| $1.25 | $60.82M | -0.31 | -3.2% | -10.23% | -142.49% | — | |
| $30.51 | $1.86B | -1.50 | 2.15% | -13.15% | -41.8% | — | |
| $8.65 | $780.35M | 7.86 | 18.95% | 8.75% | 24.65% | — | |
| $4.35 | $130.98M | -7.50 | -2.79% | 0.34% | 2.37% | — | |
| $111.54 | $5.83B | 16.60 | 15.42% | 7.15% | 11.19% | — |
IBEX Limited (IBEX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
IBEX Limited (IBEX) SEC filings — annual & quarterly reports (10-K, 10-Q)
Sep 10, 2026·SEC
May 6, 2026·SEC
Feb 5, 2026·SEC
Get notified when IBEX posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
IBEX Limited (IBEX) stock FAQ — growth, dividends, profitability & financials explained
IBEX Limited (IBEX) reported $644.1M in revenue for fiscal year 2025. This represents a 99% increase from $323.0M in 2016.
IBEX Limited (IBEX) grew revenue by 9.8% over the past year. This is steady growth.
Yes, IBEX Limited (IBEX) is profitable, generating $46.3M in net income for fiscal year 2025 (6.6% net margin).
IBEX Limited (IBEX) has a return on equity (ROE) of 24.6%. This is excellent, indicating efficient use of shareholder capital.
IBEX Limited (IBEX) generated $31.2M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
